chrisvoncsefalvay/vaers-outcomes huggingface dataset:
itchy rash; red arm; swollen arm; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), PERIPHERAL SWELLING (swollen arm), RASH PRURITIC (itchy rash) and ERYTHEMA (red arm) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination.     No medical history reported.  Concomitant products included SIMVASTATIN and LOSARTAN POTASSIUM for an unknown indication.   On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 21-Feb-2021, the patient experienced PERIPHERAL SWELLING (swollen arm) and ERYTHEMA (red arm). On 23-Feb-2021, the patient experienced RASH PRURITIC (itchy rash). On 15-Feb-2021, PAIN IN EXTREMITY (Sore arm) had resolved. At the time of the report, PERIPHERAL SWELLING (swollen arm), RASH PRURITIC (itchy rash) and ERYTHEMA (red arm) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Treatment details included Benadryl (diphenhydramine) and cortisone cream.
Erythema on left upper arm with centrally located vesicles approx 4-5cm in diameter. Rx'd Benadryl Elixir 1/2 tsp every 6 hours; Hydrocortisone cream 1% bid and Amoxicillin 250mg tid X 10 days.
This initial spontaneous report was received from a physician referring to a 3 months old male infant. There was no pertinent medical history, concomitant medication, concurrent conditions or drug allergies/drug reactions described. On 17-SEP-2015, at 15:44 hours the patient was vaccinated with a dose of improperly stored ROTATEQ oral solution (lot # K023157 with expiration date 23-JUL-2016, second dose; dose was not reported), that was exposed to out of normal storage temperature range. No adverse event was reported. Lab diagnostics test were not performed. It was unknown if the patient sought medical attention. Product quality complaint (PQC) was not involved. This is one of several reports received from the same reporter. Additional information is not expected as all correspondence was received.
Information has been received from a registered nurse concerning a female patient who on an unspecified date was vaccinated with a dose of GARDASIL (Lot Number: 667866/1437Z). On an unspecified date the patient experienced pain in her arm after receiving the GARDASIL. It was unspecified whether the patient sought medical attention. At the time of the report, the patient's present status was unknown. A lot check has been initiated. This is one of several reports received from same source. Additional information has been requested.
Client has numbness and tingling  in hands started about a week after vaccination, and is still continuing.  11/30/2022 No energy, sinus are sore, all over body weakness, headaches, fever, - S&S are still occurring.  Client reported having COVID in OCT of 2021, and in comparison having COVID was very mild and very easy compared to this reaction.   She has been taking cold medicine, decongest, tylenol.
This spontaneous report as received from a registered nurse refers to 9 unspecified patients of unknown age and gender. The nurse reported that on unspecified dates in June 2014, the 9 patients were vaccinated with (Oka/Merck) VARIVAX (subcutaneous injection, 0.5 ml once, subcutaneous. Strength, lot #, expiration date and anatomical location not reported, that was improperly stored at a maximum of 9F for up to 28 hours. No adverse effects reported. This is one of several reports from the same source. Additional information has been requested.
metallic taste in her mouth; This is a spontaneous report from a contactable consumer or other non-health care professional (patient's husband) via Pfizer sponsored program. A female patient of an unspecified age received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number not reported) via an unspecified route of administration on 07Mar2021 as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date in Mar2021, after the 1st dose 2 -3 hours, the patient experienced metallic taste in her mouth. Patient called the pharmacist and recommend a benadryl 1 tablet. The outcome of the event was unknown.  Follow-up attempts completed. No further information expected.
patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No allergies reported.  Concomitant medication information was not provided by the reporter.  Treatment information was not provided by the reporter.
Patient came to me (11/16/18) and stated she started having a sore arm with itching that started yesterday. She did say that she has been cleaning house and didn't know if she had caused something to happen or if it was the vaccine she was having a reaction to.
suspected vaccination failure; I have them now.; This case was reported by a consumer via media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine and the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles was not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.  Additional details were provided as follows: This case was reported by the patient himself/herself. The age at vaccination was not reported. The patient had received both shots of Shingles vaccine but still got shingles and till the time of reporting, the patient still had them. The follow-up would not possible as no contact details were available. This case was considered as suspected vaccination failure since the details regarding time to onset and laboratory test confirming shingles were unknown at the time of reporting.
Fever, redness, itching, swelling on the upper part of the arm to shoulder joint and top of clavicle, soreness.
Presented with SOB/cough/fever x 2days; +covid in ED; CXR - multifocal PNA type pattern, dx: Covid PNA; Labs: D dimer 0.42; CRP 4.1; Ferritin 250.; Tx: Zithromax, remdesivir, Rocephin, Decadron, Singulair, Xarelto, Zinc; Initially on 3-4 LPM supplement O2; down to room air by d/c
Patient developed maculopapular rash over entire body and face and extremities, along with fevers up to 104 within 24 hours of vaccine.
This spontaneous report was received from another health professional who refers to a 52 years old female patient with dyslipidemia, diabetes mellitus, sulfur allergy and GERD. The patient was vaccinated into left deltoid with a first dose of PNEUMOVAX23 (dose and route not reported) (lot# reported as H013399) on 23-OCT-2012 09:30. Other suspect therapies included FLUAD administered into left deltoid (dose, route not reported, lot # 12099d) on 23-OCT-2012. Concomitant medications included metformin, NEXIUM and atorvastatin. On 23-OCT-2012 the patient experienced localized severe deltoid pain, wheals on out upper left arm and 102 F fever. It was reported that the patient required ER/doctor visit (unspecified). The outcome of all adverse events was reported as unknown. Additional information has been requested.
Information was received from a nurse referring to a patient who was an adult of unknown age and gender. The patient's medical history and concurrent condition were not reported. On 13-JUN-2016 the patient inadvertently received a pediatric dose of VAQTA (lot # M009377, expired on 17-JUN-2017) 0.5 ml (route unknown). No adverse effect was reported. Additional information is not expected as there was no consent for follow up.
Received shot left deltoid at 445pm did fine until 0800pm said left eye was swollen/itchy. small hives noted around eyes and both eyes swollen left worse. Gave 12.5mg oral benadryl at 0805pm. 0845 lower lip swollen mainly on left side. No respirator issues/no throat or tongue issues. Sleep well. Eyes mildly swollen in am. Feels fine want to go to school.
Client stated she had an immediate headache, nausea, and felt her throat was scratchy. This reaction occurred within five minutes after the injections. BP was 124/74 at fifteen minutes. Discussed incident with a NP who instructed to give water and comfort measures for now, return to her if her condition worsens. Returned to third floor to continue training. Checked in with her every 30 minutes. At the end of the day she stated she felt better.
Headache, Myalgia, Arthralgia, Fever, FATIGUE Narrative:  LEFT WORK PART DAY DUE TO SYMPTOMS, NEXT DAY
Increased erythema at vaccination site, Left upper arm, and slight to mild tenderness of left axilla. Patient complaining of flu like symptoms, low grade fever, lightheadedness.
Patient presented to the emergency department for complaints of worsening shortness of breath. Patient received the COVID vaccine 3 days into her hospitalization. Patient diagnosed with metastatic breast cancer, and passed away 18 days after presentation to the ED.
The symptoms started 9 days after the J&J shot, with very severe muscle pain (worsening during nights)  during the first week. This turned into a facial paralysis (17 days after the shot) followed by about 5 months of tingling in fingertips, fatigue and muscle pain/weakness in legs and difficulty to walk properly. I have an appointment with a neurologist in October but this will probably be too late as I felt fully recovered since about three weeks. That is why I wanted to report this to ensure that it is in the systems.
Patient recalls severe bruising; nausea, vomiting, & diarrhea lasting for the evening; & a feeling of "throat tightness".  At a previously-scheduled PCP appointment on 10/05/2010, her physician retroactively diagnosed her with experiencing anaphylaxis, according to the patient.  Says she did not feel "normal" again until 10/6 or 10/7 & resumed regular activities on 10/8.
General aches and pain; Fatigue; This is a spontaneous report from a contactable consumer. An unspecified aged adult male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 28Apr2021 as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 07Apr2021 as a single dose for COVID-19 immunisation. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 28Apr2021, the patient experienced fatigue and general aches and pain. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of reported events. The clinical outcomes of events fatigue and general aches and pain were recovered on an unknown date in Apr2021.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
This spontaneous report as received from a pharmacy technician refers to a patient of an unknown age and gender. The patient's concurrent conditions, medical history, historical drugs and concomitant therapies were not reported. On 05-OCT-2017, the patient was inadvertently vaccinated with an expired dose of PNEUMOVAX 23 lot number L019835, expiration date 23-MAR-2017 (dose and route was not reported) for prophylaxis. No adverse events were reported.
No additional adverse effect reported; underwent a temperature excursion that took place on 8/13/2021 were administered; This spontaneous report has been received from a reporter specified as other, referring to a patient of unknown age and gender. No information regarding the patient's medical history, concurrent conditions or concomitant medications was provided.  On 13-AUG-2021, the patient was vaccinated with hepatitis A vaccine, inactivated (VAQTA) (lot number U013969 has been verified to be valid, expiration date reported and established as 06-FEB-2023) and varicella virus vaccine live (Oka/Merck) (VARIVAX) (lot number T037642 has been verified to be valid, expiration date reported and established as 06-NOV-2022) as prophylaxis (doses, routes of administration, anatomical sites of vaccination and vaccine schemes were not reported).   The vaccine hepatitis A vaccine inactivated (VAQTA) was exposed to a temperature excursion of below 36 degrees Fahrenheit (32.9°F) during a time frame of 90 hours. The vaccine varicella virus vaccine live (Oka/Merck) (VARIVAX) was exposed to a temperature excursion of 14 degrees Fahrenheit to 46 degrees Fahrenheit (32.9°F) for 90 hours (product storage error).  There was no previous temperature excursion. No additional adverse event (no adverse event) was reported.   This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2109USA003185:
Symptoms started about 5 and a half hours after vaccine. Extreme dizziness that i couldn?t even stand up. It is now 2 weeks since the vaccine and I?m still in a constant fog and dizziness. I have seen specialists Ent and my pcp. They are now referring me to neurology
Fever, redness and pain, hard at injection site, hot to the touch for 2 days after shot.
20x14 cm red blotchy indurated eruption at site but did not occur until a week post injection.  No fever or adenopathy.   Treated by local hydrocortisone cream. The next day less red but no other changes. Seems like typical local reaction but was slower to emerge than I found in the literature
pt called at 10am to report that when she woke up at 6am that she had red hot welts on her face and red hot blochy patches all over her body. they hurt to touch., she took benadryl at 6am but it still looked the same and felt the same at 10am.
about 24 hours after the shot I developed a fever that hovered between 99.5 and 99.9 for about 12 hours... by 10:30 that night my fever went away... no other symptoms - I was surprised that my fever started 24 hours after the shot because from what I hear it?s usually 12 hours
Pt has anxiety to vaccines and fainted. She felled off the chair and regained consciousness within minutes.
I received my booster COVID shot 09/30/2021. Overnight, began to have expected body aches, joint pains, headache, fatigue. 10/03/2021 the body aches and joint pains were nearly resolved, but the headache and fatigue persisted. I also developed that day a scratchy/irritated throat. Not sore. 10/04/2021 I developed a runny nose with clear drainage. 10/05/2021 I was also congested. I was tested for COVID, which resulted positive. I received monoclonal antibody treatment 10/07/2021 with resolution of my respiratory symptoms.  10/15/2021 I developed random bouts of tachycardia, with no precipitating factors. Heart rate up to 120-130bmp. 10/18/2021 I presented to the emergency room for evaluation after a bout lasted for 1.5 hours. My EKG and laboratory work were normal, except a potassium level of 3.3 and a d-dimer of 0.53. This has persisted intermittently since.  I was reevaluated by my primary care provider 10/25/2021. My d-dimer has returned to normal at 0.48. I will complete an echocardiogram and wear a ZIO patch in the near future for further evaluation.  Writer was asked per phone call 10/22/2021 from CDC (based on v-safe check in answers) to file VAERS report.
noticed sl redness/hardness considered nl rxn by 26MAR97 was significant enough hat noticed it;itching;DPH cream applied;27MAR97 to clinic induration 90mm x 42mm; instructed to see PMD to eval for cellulitis erythema;
At 6:45 pm my mouth started to get tingly/numb and then eyes began to swell up.  I had spots/hives on my body - not many - on the chest area.  Then my hands/fingers and feet became itchy.  throat tigh; At 6:45 pm my mouth started to get tingly/numb and then eyes began to swell up.  I had spots/hives on my body - not many - on the chest area.  Then my hands/fingers and feet became itchy.  throat tigh; At 6:45 pm my mouth started to get tingly/numb and then eyes began to swell up.  I had spots/hives on my body - not many - on the chest area.  Then my hands/fingers and feet became itchy.  throat tigh; At 6:45 pm my mouth started to get tingly/numb and then eyes began to swell up.  I had spots/hives on my body - not many - on the chest area.  Then my hands/fingers and feet became itchy.  throat tigh; At 6:45 pm my mouth started to get tingly/numb and then eyes began to swell up.  I had spots/hives on my body - not many - on the chest area.  Then my hands/fingers and feet became itchy.  throat tigh; throat tightened up due to swelling -; I couldn't breathe; This is a spontaneous report from a contactable consumer (patient). A 48-year-old male patient received bnt162b2 (BNT162B2, solution for injection, Batch/Lot Number: EN9581), via an unspecified route of administration in left arm on 07Feb2021 at 03:00 PM as single dose for covid-19 immunisation. Medical history included none. Concomitant medication included pantoprazole at 40mg taken for an unspecified indication, start and stop date were not reported. The patient had no known allergies. The patient not had COVID-19 prior vaccination. The patient was not tested with COVID-19 post vaccination. The patient reported that his mouth started got tingly/numb and then eyes began to swell up, had spots/hives on body - not many - on the chest area, then hands/fingers and feet became itchy, throat tightened up due to swelling, but nothing serious where couldn't breathe on 07Feb2021 18:45. The outcome of events was recovered on Feb2021. Therapeutic measures were taken for the events swelling and hives with Benadryl.  Follow-up activities have been completed and no further information is expected.
Enlarged lymph node on left neck started on day 2 and use still ongoing. Yesterday afternoon, my neck pain got so bad that I had radiating pain shooting down and numbness to my left fingers. I took Tylenol and felt better. This morning, I have the pain again on left side of my neck with occasional numbness. I had really bad sore arm that I couldn't lift my arms but that's fine now. With third dose, I also had nausea but I am fine now.
Elevated blood pressure that was not affected by various treatments. I can't remember the medication. Severe headache with blurred vision. Also episodes of hypoglycemia.
Sudden loss of blood pressure 6 hours after injection. Dropped me like a stone into the street.
(05/11/21 - second dose administered) sore arm at point of injection.   (05/12/21) sore arm at point of injection, fatigue, muscle soreness in upper back, headache, fever, cold chills, nausea, diarrhea.   (05/13/21) sore arm at point of injection, fatigue, muscle soreness in upper back, muscle soreness in neck, headache, fever, cold chills, nausea, vomiting, diarrhea.   (05/14/21 today?s date) sore arm at point of injection, fatigue, muscle soreness in neck, nausea, diarrhea.
Heavy vaginal bleeding.  Lasting for about a week.  Stopped a few days.  Started again and lasted about another week.  Stopped for a couple days.  Started again and lasted about 10 days.  Stopped for about a week and started again.  Also having fatigue/exercise intolerance.  Not sure if from vaccine, but I seem to have less energy since vaccine.
Initial unsolicited report received from a healthcare professional (nurse practitioner) on 13 August 2015. A 43-year-old male patient, whose medical history and concomitant medications were not reported, had received a dose of TENIVAC (batch number was unknown, route and site of administration were not reported) on 30 April 2015. Illness at time of vaccination and pre-existing allergies, birth defects, medical conditions were not reported. On 30 April 2015, same day within 30 minutes after vaccination, the patient experienced pain in arm and dizziness. He also stated that events continued till 13 August 2015. The patient also experienced chest pain, lightheadedness, and nausea on unspecified date. Laboratory investigations and corrective treatments were not reported. Patient required ER doctor visit. At the time of this report, the patient was not recovered from the events. Documents held by sender: none.
Due to my personal history of atypical cells in left breast, I had my routine annual MRI the day after my vaccine booster.  the MRI noted two enlarged lymph nodes.
Syncope post vaccination.   Emergency response team called (MD). Patient evaluated by MD, Vital signs checked 3 times. Provided with drinks. Discharged home by MD physician.
Mother calls after the child received vaccines in the morning hours and then went to school. Mother states child's are has a softball size area where vaccines were administered and is red and hot to touch. Mother denies any difficulty breathing, lip/tongue swelling. Mother states school nurse gave child oral Benadryl at school. Instructed mother to apply ice pack to site and call primary physician for further instruction and if symptoms worsened to seek medical treatment right away. Mother agrees and states will call PCP. A follow-up call was placed the next day on 12/3/20 and spoke to child's mother. Mother states PCP stated to just watch child for any worsening of symptoms and seek treatment if needed. Mother states child returned to school that day and she had not received any calls from school nurse stating child had any further issues. Mother states child's are was less swollen and red that morning when she left for school.
VOMITED CLEAR MUCOUS 2 TIMES, 01/26/2012 VOMITED CLEAR MUCOUS 1 TIME.
Decreased BP, clammy, "feels like passing out" then became unresponsive for 5-10 sec.
Localized redness at injection site. Per patient, redness began on 04/02/19 and increased in size by 04/03/19. No swelling noted, patient denies any pain. Erythema area measured 4 in. x 2 1/2 in. and warm to touch.